The 100 Most Influential CEOs in Oncology in 2025 (Full List)

100 Most Influential CEOs

"Peace is the Best Medicine" - WHO Director-General Announces What Healthcare is Missing

Tedros Adhanom Ghebreyesus, Director-General

TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC

TWINPEAK study

CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma

CheckMate 9DW

Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma

Anal Squamous Cell Carcinoma

Adham Jurdi Has Been Appointed Sr Medical Director of GI Oncology and Innovations at Natera

Adham Jurdi

CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer

CRITICS-II Trial

Highlights from ASCO GI 2026 by Wafik El-Deiry

ASCO GI 2026

Vivian Li